HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Year Made Unusual By COVID-19, Still More Unusual Consumer Health Claims Surface In US

Executive Summary

An ultraviolet lamp marketer was dinged by industry self-regulation for COVID-19 claims; the largest US natural  food grocery chain had one too many undeclared allergens for the FDA's liking; and warnings note cannabidiol-containing eye drops, nasal sprays and inhalers promoted with drug claims.

You may also be interested in...



Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request

FDA’s justification report published with Biden administration’s FY2022 federal budget request includes $1.194bn for agency’s food programs, which include its oversight of supplement industry, up from $1.11bn in FY2021 appropriation.

Ginger, Mushroom, Aloe Supplements Get US FDA Warnings For Disease Claims

Three firms were warned after FDA inspectors reviewed their websites or social media posts. No facility inspections nor warnings about GMP problems were noted in the letters.

Like Kentucky’s Senior Senator, Paul Hoists Legislative Flag For US Hemp Industry Growth

Sen. Paul’s HEMP Act would raise from 0.3% to 1% the level of THC by dry weight in hemp under the 2018 farm bill. The bill also would require testing for THC levels in final products containing cannabinoids and other hemp-derived ingredients rather than within 15 days of harvest.

Related Content

Topics

UsernamePublicRestriction

Register

RS150837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel